AstraZeneca plc is a British-Swedish multinational pharmaceutical and biopharmaceutical company. In 2013, it moved its headquarters to Cambridge, UK, and concentrated its R&D in three sites: Cambridge; Gaithersburg, Maryland, USA for work on biopharmaceuticals; and Mölndal in Sweden, for research on traditional chemical drugs. Read More
Bangladesh on Thursday approved procurement of 30 million doses of Covishield COVID-19 vaccine from India, co-developed by European pharmaceutical company AstraZeneca and Oxford University. ...
A volunteer in Brazil's clinical trial of COVID-19 vaccine being developed by AstraZeneca and Oxford University has died, the Brazilian health agency Anvisa announced on Wednesday while adding that the trial will continue. ...
Ekaterina Ivanova - Any safe and effective vaccine against COVID-19 may not need to be administered annually, unlike vaccines for influenza, Dr. Richard Mihigo, the program area manager for immunization and vaccine development at the World Health Org ...
Canadian Prime Minister Justin Trudeau on Friday announced that his government has entered into an agreement with British pharmaceutical giant AstraZeneca to procure 20 million doses of its coronavirus vaccine. ...